Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
arsenic sulfide
- Development stage
- Phase 4
- Lead developer
- Shanghai Jiao Tong University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Arsenic sulfide is an inorganic compound that is a main component of realgar, a substance widely used in traditional Chinese medicine. It is being investigated for its anti-cancer properties, particularly in hepatocellular carcinoma (HCC), gastric cancer, and hematological malignancies like acute promyelocytic leukemia (APL). Its mechanism of action involves inducing apoptosis through the activation of caspases and modulation of pro- and anti-apoptotic proteins, inhibiting cell proliferation by affecting cell cycle progression and key signaling pathways such as PI3K/AKT and MAPK, and suppressing the expression of proteins like TLCD1 and Ki-67. Additionally, arsenic sulfide inhibits tumor cell migration and invasion, reverses epithelial-mesenchymal transition (EMT), and targets the HIF-1/VEGF and Notch pathways, as well as the STAT3-THBS1/CD47 pathway, to exert its anti-tumor effects.
02
Targets
BAX (Apoptosis regulator BAX)CASP3 (Caspase-3)CASP9 (Caspase-9)HES1 (Hairy and Enhancer of Split 1 Protein)HIF1A (Hypoxia-inducible factor 1-alpha)NOTCH (Neurogenic locus notch homolog protein 3)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)STAT3 (Signal Transducer and Activator of Transcription 3)CD47 (Cluster of Differentiation 47)VEGFA (Vascular endothelial growth factor A)MYC (MYC proto-oncogene protein)
Beyond the preview
Go deeper on arsenic sulfide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on arsenic sulfide.